New technology for an old disease

Slides:



Advertisements
Similar presentations
Di Riley Associate Director, Clinical Outcomes NCIN
Advertisements

TB and poverty agenda in WPR WHO/WPRO Stop TB. World Health Organization Percentage of population living below US$1 a day.
Referral of participants for HIV follow-up care Africa Centre MDP experiences Presented by: Hlengiwe Ndlovu MDP Clinic coordinator.
Washington D.C., USA, July 2012www.aids2012.org A National Program Manager’s Perspective on HIV/TB Integration Dr Owen Mugurungi Director – AIDS.
World TB Day 2011 March 24, 2011 Mavuso Centre Manzini – Kingdom of Swaziland.
Systematic TB Screening: Philippine Experience The 9th Technical Advisory Group and National TB Program Mangers meeting for TB control in the Western Pacific.
Factors Associated with Interruption of Treatment Among Pulmonary Tuberculosis Patients in Plateau State, Nigeria, 2011 Luka M. Ibrahim 1, P. Nguku 1,
Accelerating PMDT scale up in Ethiopia
Introduction Hypothesis Conclusions Specific Aims In-home Intervention Improves Outcomes of Tuberculosis Patients in Zimbabwe, Africa Olga Kishek, Tess.
The ninth Technical Advisory Group and National TB Managers meeting
COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU.
experience from Lesotho
Action Plan Prepared by : Ismat Ara Khusheed Deputy Director,PTP Sindh At JAPAN 2006 At JAPAN 2006.
22 March 2012 Europe and ACP together against tuberculosis European Parliament, Rue Wiertz 60 BRUSSELS Charles S Mgone EDCTP Executive Director.
Molecular methods for TB drug resistance testing: what is needed? Experience from Khayelitsha, Cape Town, South Africa Helen Cox, PhD, Burnet Institute.
Reduced treatment delays for drug-resistant TB/HIV co-infected patients with decentralised care and rapid Xpert MTB/Rif test in Khayelitsha, South Africa.
MDR-TB: a fight we cannot afford to lose! Alexander Golubkov, MD, MPH Senior TB Technical Advisor.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
DRUG-RESISTANT TB in SOUTH AFRICA: Issues & Response _ ______ _____ _ ______ _____ ___ __ __ __ __ __ _______ ___ ________ ___ _______ _________ __ _____.
Multi-drug resistant tuberculosis: Progress and challenges in South Africa Dr S. Moyo HIV/AIDS, Sexually Transmitted Infections and TB research (HAST)Programme.
A decentralized model of care for drug-resistant tuberculosis in a high HIV prevalence setting Cheryl McDermid, Helen Cox, Simiso Sokhela, Gilles van Cutsem,
Outcomes among patients treated for tuberculosis in Limpopo Province, South Africa, Mmakgotso Pilane, Lazarus Kuonza, Eric Maimela.
Action Plan Good Health Situation of Population in Capital of Myanmar Yangon Division By DR MYA THIDA AYE.
Our vision: Healthier communities, Excellence in healthcare Our values: Teamwork, Honesty, Respect, Ethical, Excellence, Caring, Commitment, Courage DOTS.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
Project Goals  Support the National Tb Program (NTP)  Developed National Guidelines for prevention and control of Tb  Developed guidelines for treating.
Implementation of Thin Layer Agar for Mycobacterium culture in rural Kenya Médecins Sans Frontières.
ACTION PLAN FOR TUBERCULOSIS CONTROL PAPUA NEW GUINEA DR. JOSEPH BANA-KOIRI.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
HRD IN RESPOND TO AIDS, TB, MALARIA AND MDGs IN VIETNAM.
Surveillance Data in Action: Tuberculosis Indicators Melissa Ehman, MPH Tuberculosis Control Branch (TBCB) Division of Communicable Disease Control Center.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
Dana Farcasanu Foundation Center for Health Policies and Services
Washington D.C., USA, July 2012www.aids2012.org Implementing Xpert ® MTB/RIF in Rural Zimbabwe Impact on diagnosis of smear-negative TB and time-
Tuberculosis control in Suriname Situational analysis.
Scale up TB/HIV activities in Asia Pacific 8-9Aug09 1 TB/HIV collaborative activities in Thailand Sriprapa Nateniyom, M.D. TB Bureau, Department of Disease.
MSF TB Program for Migrants in Tak. Beginnings: MSF TB Programs in Thailand First MSF TB Program in Thailand started in 1985 in Karen camps (Shoklo,
H Bygrave L Triviño L Makakole Medecins sans Frontieres Lesotho Scott Hospital Morija TB/HIV Integration Lessons learned from implementation of a TB/HIV.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Introduction of outpatient care for DS-/MDR-TB patients in Tajikistan Cape Town, December 02-06, 2015.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
Global Fund Grant Proposal Round 11: Tuberculosis Nathan Furukawa Gabriella Boyle Rebekah Miner Paa Kobina Forson Xiaoxue Huang Hunter Pugh Gap Analysis.
Firma A. Kisika 1, Duncun Ndimbo 1, Rhoda Kunzugala 2, Richard Mkinga 3, Nolasco Ngoloka 2,, DMOs& DCDOs Iringa 1, Kilolo 2 and Mbinga 3 District Councils.
Strengthening TB and HIV&AIDS Responses in East Central Uganda Strengthening Laboratory TB diagnostic capacity of peripheral laboratories in East Central.
The CQUIN Learning Network: Partnering to Advance Differentiated Care
TB- HIV Collaborative activities in Romania- may 2006 status
financial requirements
Tuberculosis in children in Uzbekistan: Don’t forget drug-resistant TB Junia Cajazeiro, Atadjan Khamraev, Philip Du Cros, Tleubergen Abdrasuliev, Joan.
First roll out of universal access to antiretroviral therapy under routine program conditions in rural Swaziland. Authors: Bernhard Kerschberger (1), Sikhathele.
Country Progress Report Cambodia
Drones for Development & Humanitarian Response in Malawi
1 Results Background RSBY – What is the Scheme?
PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
The intersection between diabetes and tuberculosis: a perspective
Progress: Bangladesh CCM GF SEA Constituency Meeting New Delhi, India
Pre-conference Meeting Report
Progress in Implementation of TB/HIV Collaborative activities
Knowledge gaps in formulating TB Control Policies for Prisons
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Impact of Using Fixed Dose Combinations (FDCs) versus
Impact of Using Fixed Dose Combinations (FDCs) versus
Objectives of Session Provide an overview of the development of Compendium Explain the organization of the Compendium and how indicators are used Provide.
3rd Global WG on TB/HIV, Montreux, 4-6 June, 2003
WS on Surveillance & Epidemiology
DOTS EXPANSION AND BEYOND DOTS World Health Organization
Cheng shiming National TB Center in China May,3, 2004
Lucas Molfino, MSF Mozambique
A pathway to policy commitment for sustainability of a key population-led health services model in Thailand Dr. Preecha Prempree Deputy Director-General,
Presentation transcript:

New technology for an old disease Unmanned Aerial Vehicles for tuberculosis sample transport in Papua New Guinea -- September 2014

Papua New Guinea 22 provinces Capital: Port Moresby/NCD Population: 7 million More than 800 ethnic groups 80% remote rural populations MSF presence: OCA & OCP OCP TB program in Gulf since May 2014

Tuberculosis burden Incidence - 346/100 000 Prevalence - 534/100 000 3rd cause of morbidity & mortality HIV/TB Coinfection:10% DRTB - 4.9% in new and 23% in retreatment Poor program outcomes > 50% PTB diagnosed without smear National success rate 69% (27% in Gulf) High defaulter rate: officially 19% but reported as high as 75%

Project set-up Close collaboration with NTP Central TB diagnostic and treatment centre Decentralized patient follow-up Average 50 patients enrolled /month 75% new cases 68% PTB 4% DRTB 25% under 15 years old Decentralised diagnosis and follow-up is the key to the success of

Challenges in Gulf Difficult access to remote health centers Biggest swamp in the world Only one road to go to the capital of the province Bad sea several months per year. Need to be innovative to bring diagnostic samples to MSF laboratory

Medical needs Medical-operational request: How to move Tuberculosis diagnostic samples from remote health centers to MSF laboratory in shortest possible time. Pre-requisite : System simple to use All season & Robust to face difficult weather conditions Safe and robust case to transport Tuberculosis samples

Matternet Profile American company based in California Already made a test in Haiti in 2012 UAV Electric system Up to 28km

UAVs trial

Results Papua New Guinea authorities supportive to the trial Feasibility test Test with a 500 gram load Good in wind up to 36 km/hour Good acceptance from the population But… Short range so far Need human action to swap batteries Still a product in development and not yet mature

Questions & future Is this technology too young to be reliable? Can we deploy it and if so can we scale it up? Can we afford it? Can we technically handle it internally or we will always need external support Will it be accepted in other countries? Where are we now? Contacts ongoing with other companies working on this technology Hopefully we will do another trial phase in 2015 More questions than answers

Acknowledgement Ministry of Health – Papua New Guinea Civil Aviation Authorities – Papua New Guinea Provincial Health Department – Gulf Province, Papua New Guinea For facilitating and authorizing this trial Matternet for binging technology and expertise OCP MSF team for organizing and coordinating this trial phase.